Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02427087
What this trial is testing

Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity

Who this might be right for
Fatty Liver
University of Sao Paulo General Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT04147195
What this trial is testing

Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT05795517
What this trial is testing

Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）

Who this might be right for
Hypercholesterolemia
Haisco Pharmaceutical Group Co., Ltd. 210
Not applicableLooking for participantsNCT05720663
What this trial is testing

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Virginia Commonwealth University 240
Testing effectiveness (Phase 2)Ended earlyNCT02787304
What this trial is testing

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis
Mirum Pharmaceuticals, Inc. 197
Testing effectiveness (Phase 2)Study completedNCT00794716
What this trial is testing

PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Norgine 125
Testing effectiveness (Phase 2)Study completedNCT02466516
What this trial is testing

Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Gilead Sciences 72
Early research (Phase 1)Study completedNCT05680233
What this trial is testing

Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver
Oasis Pharmaceuticals, LLC 24
Testing effectiveness (Phase 2)Study completedNCT03912532
What this trial is testing

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 171
Testing effectiveness (Phase 2)Study completedNCT02781584
What this trial is testing

Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Nonalcoholic Fatty Liver Disease (NAFLD)
Gilead Sciences 220
Not applicableStudy completedNCT04988230
What this trial is testing

Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
Nanfang Hospital, Southern Medical University 88
Not applicableStudy completedNCT07200934
What this trial is testing

Effect of Adding TENS to Mediterranean Diet on Appetite and Liver Enzymes in Nonalcoholic Fatty Liver Patients

Who this might be right for
Nonalcoholic Fatty Liver
Cairo University 50
Testing effectiveness (Phase 2)Ended earlyNCT03511365
What this trial is testing

Effects of Probiotic on Inflammation and Microbiota in Patients With NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseProbiotics MeSH Descriptor Data 2018Interleukin-17 MeSH Descriptor Data 2018
Northwell Health 6
Post-approval studies (Phase 4)Looking for participantsNCT06368882
What this trial is testing

Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）

Who this might be right for
Nonalcoholic Fatty Liver DiseaseChronic Hepatitis b
First Affiliated Hospital of Wenzhou Medical University 1,500
Testing effectiveness (Phase 2)Study completedNCT04166773
What this trial is testing

Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Eli Lilly and Company 190
Not applicableStudy completedNCT02412540
What this trial is testing

Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH

Who this might be right for
ObesityNonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease
Children's Hospital Medical Center, Cincinnati 62
Early research (Phase 1)UnknownNCT05655221
What this trial is testing

A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects

Who this might be right for
Nonalcoholic Steatohepatitis
Tasly Biopharmaceuticals Co., Ltd. 56
Not applicableUnknownNCT04783116
What this trial is testing

Plant Stanols and Liver Inflammation in Overweight and Obese Children

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisNAFLD+5 more
Maastricht University Medical Center 52
Post-approval studies (Phase 4)Study completedNCT05813249
What this trial is testing

Semaglutide in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Zagazig University 180
Testing effectiveness (Phase 2)WithdrawnNCT04371653
What this trial is testing

A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus
The University of Texas Health Science Center, Houston
Next Page